Format

Send to

Choose Destination
Am J Physiol Endocrinol Metab. 2013 Sep 15;305(6):E745-50. doi: 10.1152/ajpendo.00289.2013. Epub 2013 Jul 30.

Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo.

Author information

1
Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.

Abstract

Insulin stimulates microvascular recruitment in skeletal muscle, and this vascular action augments muscle glucose disposal by ∼40%. The aim of the current study was to determine the contribution of local nitric oxide synthase (NOS) to the vascular actions of insulin in muscle. Hooded Wistar rats were infused with the NOS inhibitor N(ω)-nitro-L-arginine methylester (L-NAME, 10 μM) retrogradely via the epigastric artery in one leg during a systemic hyperinsulinemic-euglycemic clamp (3 mU·min(-1)·kg(-1) × 60 min) or saline infusion. Femoral artery blood flow, microvascular blood flow (assessed from 1-methylxanthine metabolism), and muscle glucose uptake (2-deoxyglucose uptake) were measured in both legs. Local L-NAME infusion did not have any systemic actions on blood pressure or heart rate. Local L-NAME blocked insulin-stimulated changes in femoral artery blood flow (84%, P < 0.05) and microvascular recruitment (98%, P < 0.05), and partially blocked insulin-mediated glucose uptake in muscle (reduced by 34%, P < 0.05). L-NAME alone did not have any metabolic effects in the hindleg. We conclude that insulin-mediated microvascular recruitment is dependent on local activation of NOS in muscle and that this action is important for insulin's metabolic actions.

KEYWORDS:

hyperinsulinemic-euglycemic clamp; microvascular blood flow; muscle blood flow; nitric oxide; nitric oxide synthase

PMID:
23900417
DOI:
10.1152/ajpendo.00289.2013
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center